Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs

Today, 7:07 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)

ABCL

3 minute read

What 3 FibroGen Analysts Are Expecting From Thursday’s Roxadustat Adcom Verdict

By Shanthi Rexaline

Today, 7:07 AM

FibroGen, Inc. (NASDAQ: FGEN) has a key catalyst Thursday when FDA's Cardiovascular and Renal Drugs Advisory Committee will issue its recommendation on the company's new drug application for roxadustat. The committee is scheduled to meet between 9:30 a.m. and 5:30 p.m.

AZN

3 minute read

The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix

By Shanthi Rexaline

Today, 7:07 AM

Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow.

ALEC

5 minute read

Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates

By Shanthi Rexaline

Today, 7:07 AM

June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive verdicts, and rejections or no-decisions were few and far between.

ALBO

6 minute read

14 Biotech Stocks To Watch Over The Next 6 Months

By Shanthi Rexaline

Today, 7:07 AM

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks.

AERI

1 minute read

FibroGen In-Licenses Three HiFiBiO Programs For Cancer, Autoimmune Settings

By Vandana Singh

Today, 7:07 AM

FibroGen Inc (NASDAQ:FGEN) and HiFiBiO Therapeutics have entered into a licensing agreement for three programs in the immuno-oncology and autoimmune space.…

FGEN

13 minute read

Uncategorized

Earnings Scheduled For May 10, 2021

By Benzinga Insights

Today, 7:07 AM

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.

ACEL

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 7:07 AM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL

2 minute read

7 Blockbuster Drugs Expected To Be Launched In 2020

By Shanthi Rexaline

Today, 7:07 AM

Biotech stocks had a fairly decent run in 2019, thanks to record deal flow, several path-breaking innovation in…

AIMT